NARKASA
1.7.2020 11:02:10 CEST | Business Wire | Press release
The global cryptocurrency market is currently worth almost $265 billion, with nearly $70 billion in transactions carried out every day. Meanwhile, 314 cryptocurrency exchanges are now in operation worldwide, according to Coinmarketcap. At most of these exchanges, however, cryptocurrencies can only be bought with US dollars or euros.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200701005057/en/
But this isn’t the case with Narkasa , an Istanbul-based cryptocurrency exchange that allows investors to buy crypto-assets with a number of different currencies. What’s more, the new service is offering a 50-percent fee discount on all transactions carried out within 90 days of its launch.
‘156 currencies from around the world’
With cutting-edge technology and services available in 12 languages, Narkasa provides investors with a platform for fast and secure cryptocurrency trading in a range of currencies. “Along with the dollar and euro, Narkasa supports transactions in Russian rubles, Ukrainian hryvnias, Brazilian reals, Kazakhstani tenges, and Turkish liras,” Narkasa CEO Erdal Kaya said.
“And we’re planning to expand our operations further to allow crypto-trading in 156 different national currencies,” he added. “Unlike most other exchanges, Narkasa will allow investors to purchase cryptocurrency from whatever country they happen live.”
Safe, reliable cryptocurrency trading
Narkasa doesn’t charge any commissions on the purchase of cryptocurrency through its platform and also guarantees that all its clients’ personal data is safe and secure. Regularly assessed by independent auditing companies, the firm operates in accordance with the EU’s anti-money laundering/counter-terrorist financing laws, while also adhering to “know your customer” guidelines.
Moreover, through the use of API technology, Narkasa provides a platform for algorithmic cryptocurrency trading. This allows clients to manage their investments using artificial intelligence specifically designed to protect against abrupt market fluctuations.
Cryptos taking world by storm
The number of cryptocurrencies now in use currently stands at 2,687, with Bitcoin, Ethereum, Tether, and Ripple accounting for 82 percent of total trade volume, which continues to surge at a dizzying pace. The proliferation of cryptocurrency exchanges, meanwhile, has led to a dramatic rise in the number of those investing in the sought-after commodity.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005057/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
illumynt Appoints Anthony Giannetti as Senior Vice President of Global Operations16.7.2026 13:00:00 CEST | Press release
Seasoned operations leader brings two decades of OEM and ITAD experience, including Dell, Apple, and Microsoft, as illumynt scales its global AI hardware lifecycle platform illumynt, a technology-driven leader in AI hardware lifecycle recovery and IT asset disposition (ITAD), today announced that Anthony "Tony" Giannetti has joined the company as Senior Vice President of Global Operations, effective July 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716696044/en/ Anthony Giannetti, SVP Global Operations Giannetti brings more than two decades of operations and supply chain leadership from some of the technology industry's largest OEMs, including Dell, where he managed reverse supply chain operations, and Apple and Microsoft, where he held additional operations leadership roles. His background spans production engineering, reverse logistics, and large-scale operational management, disciplines directly relevant to
Compvide™ Announces Strategic Collaboration with OpZira™ to Accelerate Growth and Advance the CIMED™ Platform16.7.2026 12:47:00 CEST | Press release
Compvide, Inc., a biotechnology company pioneering functional complement intelligence through innovative diagnostics and immune-response monitoring, today announced a strategic collaboration with OpZira, Inc. to support the company’s continued growth and accelerate development of its proprietary CIMED platform. Through the collaboration, OpZira will provide comprehensive operational support across clinical, customer care, finance, manufacturing, marketing, quality, and regulatory functions,” stated Clark Tedford, Ph.D., President and CEO, OpZira, Inc. “By leveraging OpZira’s established operational infrastructure and expertise, Compvide can remain focused on advancing its scientific innovation while expanding its capabilities in complement-focused diagnostics and translational medicine.” “Partnering with an experienced organization that understands the unique needs of emerging healthcare companies is an important step for Compvide as we continue building the company,” said Sadam Yaseen
Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy16.7.2026 12:35:00 CEST | Press release
Post-hoc analysis of support methods used in an open-label Phase 2 COMP360 study showed monitoring and support provided during treatment administration sessions were minimal, non-directive and distinct from conventional conceptions of psychotherapyFindings published in the Journal of Psychopharmacology Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a post-hoc analysis of support methods used in an open-label Phase 2 study of investigational COMP360 synthetic psilocybin treatment in patients with post-traumatic stress disorder (PTSD). Documented speech production between participants and support providers during treatment administration sessions showed minimal interaction. Monitoring and support were linked by patients to presence, availability, reassurance and validation. The limited and non-directive nature of these interactions distinguishes this fo
Circus Commences Operations with Ukrainian Ground Forces16.7.2026 12:04:00 CEST | Press release
Circus SE (WKN: A2YN35 / ISIN: DE000A2YN355 / XETRA: CA1), today announces the commencement of live operations of its robotic-based troop supply technology with the 3rd Army Corps of the Ukrainian Ground Forces in the Kyiv area – marking the first ever use of autonomous meal supply systems within an active conflict environment. Ahead of deployment, Circus received regulatory certification from the State Service of Ukraine for Food Safety and Consumer Protection. This certification confirms compliance with all applicable health, quality, and safety standards required to import the company's technology into Ukraine, and clears the path for operational use at scale. Soldiers are supplied using Circus's full technology stack, comprising the hardware system, AI-controlled software, and proprietary ingredient infrastructure that underpins autonomous meal production in military environments. The deployment marks Circus's entry into the Ukrainian market and the operational commencement of the
Fourthline and Veridas Join Forces to Fight Identity Fraud with a Global Identity Platform16.7.2026 11:21:00 CEST | Press release
Founded in Europe, now with global reach: backed by European investors and bringing bank-grade European compliance standards to markets worldwide Customer Value: A streamlined, end-to-end user experience that protects identity across the entire customer lifetime and helps customers grow revenue safely and compliantly. The Expected Result:Fourthline and Veridas are joining forces to create a global bank-grade identity platform: sovereign AI, modular compliance, and proprietary anti-fraud and biometric technology across Europe, Latin America, and the US. One trusted partner for end-to-end KYC, AML, and Identity compliance. Terms of Deal: Following completion of the merger, Veridas shareholders (including BBVA) will continue as shareholders in the combination, and the transaction will be partially funded by existing Fourthline investor Finch Capital and new investors including Rabo Investments, the captive investment arm of Rabobank. Expected close is in the second half of 2026, pending c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom